The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.
More than half of older American women with early breast cancer may get more radiation therapy than needed, which significantly boosts medical costs, a new study indicates.